GoodRx (GDRX) awards 54,494 RSUs to Chief Accounting Officer Thomas Chan

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Chan Thomas (TC) reported acquisition or exercise transactions in this Form 4 filing.

GoodRx Holdings, Inc. reported that Chief Accounting Officer Thomas Chan received a grant of 54,494 restricted stock units (RSUs), each representing a contingent right to receive one share of Class A common stock. The award vests in 1/12 increments quarterly starting on August 15, 2026, subject to his continued service. Following the reporting date, he also held 1,000 shares of Class A common stock directly.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Chan Thomas (TC)

Role Chief Accounting Officer

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Unit	54,494	$0.00	--
holding	Class A Common Stock	--	--	--

Holdings After Transaction: Restricted Stock Unit — 54,494 shares (Direct, null); Class A Common Stock — 1,000 shares (Direct, null)

Footnotes (1)

Each restricted stock unit represents a contingent right to receive one share of Class A common stock. This restricted stock units award vests with respect to 1/12 of the award in quarterly installments on August 15, 2026 and on each quarterly anniversary thereafter, subject to the Reporting Person's continued service through each applicable vesting date.

Key Figures

RSUs granted: 54,494 units Underlying shares: 54,494 shares RSU vesting start date: August 15, 2026 +3 more

6 metrics

RSUs granted 54,494 units Restricted stock units granted to Chief Accounting Officer

Underlying shares 54,494 shares Class A common stock underlying the RSU award

RSU vesting start date August 15, 2026 First quarterly vesting date for the RSU award

Vesting pattern 1/12 quarterly Installments after August 15, 2026, subject to continued service

Shares held directly 1,000 shares Class A common stock held after the reported transactions

RSU price per unit $0.0000 Reported transaction price and conversion price for RSUs

Key Terms

Restricted Stock Unit, Class A Common Stock, contingent right, vesting

4 terms

Restricted Stock Unit financial

"The filing lists a transaction in "Restricted Stock Unit" with 54,494 units granted."

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

Class A Common Stock financial

"Each restricted stock unit represents a contingent right to receive one share of Class A common stock."

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

contingent right financial

"Each restricted stock unit represents a contingent right to receive one share of Class A common stock."

vesting financial

"This restricted stock units award vests with respect to 1/12 of the award in quarterly installments."

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

Form 4 Insider Transactions: What Each Field Means →

05/12/2026 - 06:49 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Chan Thomas (TC)

(Last)

(First)

(Middle)

C/O GOODRX HOLDINGS, INC.

2701 OLYMPIC BOULEVARD

(Street)

SANTA MONICA

CALIFORNIA

90404

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GoodRx Holdings, Inc. [ GDRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Accounting Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock								1,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Unit	⁽¹⁾	05/11/2026		A		54,494		⁽²⁾	⁽²⁾	Class A Common Stock	54,494	$0	54,494	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of Class A common stock.

2. This restricted stock units award vests with respect to 1/12 of the award in quarterly installments on August 15, 2026 and on each quarterly anniversary thereafter, subject to the Reporting Person's continued service through each applicable vesting date.

Remarks:

	/s/ Gracye Cheng, Attorney-in-Fact for Thomas (TC) Chan	05/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did GoodRx (GDRX) report for Thomas Chan?

The filing shows Thomas Chan received a grant of 54,494 restricted stock units. Each RSU represents a contingent right to one share of Class A common stock, providing equity-based compensation tied to his continued service with GoodRx Holdings.

How many restricted stock units did GoodRx (GDRX) grant to its Chief Accounting Officer?

GoodRx granted Thomas Chan 54,494 restricted stock units. These RSUs convert into Class A common shares over time as they vest, aligning part of his compensation with the company’s future performance and his ongoing employment.

When do Thomas Chan’s GoodRx (GDRX) RSUs start vesting?

The RSUs begin vesting on August 15, 2026. From that date, 1/12 of the 54,494-unit award vests quarterly, as long as he continues serving the company through each scheduled vesting date.

What is the vesting schedule for the GoodRx (GDRX) RSUs granted to Thomas Chan?

The award vests in 12 quarterly installments. Starting August 15, 2026, and on each quarterly anniversary thereafter, 1/12 of the 54,494 restricted stock units vests, subject to Chan’s continued service on each vesting date.

How many GoodRx (GDRX) shares does Thomas Chan hold after the reported transactions?

After the reported transactions, Thomas Chan directly held 1,000 shares of GoodRx Class A common stock. In addition, he held 54,494 restricted stock units that may settle into Class A shares as they vest over time.

Do the GoodRx (GDRX) RSUs granted to Thomas Chan have an exercise price?

The reported RSU grant has a price per unit of 0.0000, meaning there is no exercise price. Each vested restricted stock unit entitles him to receive one share of Class A common stock without additional cash payment.